Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Relay Therapeutics Inc (NASDAQ: RLAY) was $6.74 for the day, down -4.53% from the previous closing price of $7.06. In other words, the price has decreased by -$4.53 from its previous closing price. On the day, 1.15 million shares were traded. RLAY stock price reached its highest trading level at $7.2 during the session, while it also had its lowest trading level at $6.61.
Ratios:
Our analysis of RLAY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 20.73 and its Current Ratio is at 20.73. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On April 19, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $29.
On April 13, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on April 13, 2023, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 29 ’24 when Bergstrom Donald A sold 2,686 shares for $6.38 per share. The transaction valued at 17,137 led to the insider holds 527,427 shares of the business.
Catinazzo Thomas sold 1,695 shares of RLAY for $10,814 on Apr 29 ’24. The Chief Financial Officer now owns 339,803 shares after completing the transaction at $6.38 per share. On Apr 29 ’24, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,623 shares for $6.38 each. As a result, the insider received 10,355 and left with 325,767 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 894681024 and an Enterprise Value of 197376896. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.32 while its Price-to-Book (P/B) ratio in mrq is 1.20. Its current Enterprise Value per Revenue stands at 5.587 whereas that against EBITDA is -0.542.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $13.32, while it has fallen to a 52-week low of $5.70. The 50-Day Moving Average of the stock is -14.01%, while the 200-Day Moving Average is calculated to be -25.94%.
Shares Statistics:
RLAY traded an average of 1.24M shares per day over the past three months and 1057080 shares per day over the past ten days. A total of 127.46M shares are outstanding, with a floating share count of 93.31M. Insiders hold about 29.70% of the company’s shares, while institutions hold 70.84% stake in the company. Shares short for RLAY as of 1713139200 were 10692091 with a Short Ratio of 8.65, compared to 1710460800 on 11812402. Therefore, it implies a Short% of Shares Outstanding of 10692091 and a Short% of Float of 10.39.
